Heron Neutron Medical Corp. (7799)
TWSE
Closed
Oct 7, 2026
Day's Range
515.0052 wk Range
300.00Overview - 7799 - Heron Neutron Medical Corp.
Key Statistics
Valuation
Enterprise Value
69.50B
P/E (Trailing)
‪-151.05‬
P/E (Forward)
‪61.11‬
PEG Ratio
‪-9.90‬
Price / Sales (TTM)
‪6,741.89‬
Price / Book
‪7.04‬
EV / EBITDA
‪-122.88‬
Profitability
Gross Margin
‪-1,506.34%‬
Profit Margin
‪-250.11%‬
Operating Margin
‪-28,243.85%‬
Return on Assets
‪-5.75%‬
Return on Equity
‪-7.67%‬
Ownership
Shares Outstanding
157.99M
Float
51.22M
Held by Insiders
‪68.48%‬
Held by Institutions
‪3.85%‬
Price stats
50-Day Avg
‪393.00‬
200-Day Avg
‪408.35‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
4 analysts
Average price target
‪NT$ 980.00‬Market Cap - 7799 - Heron Neutron Medical Corp.
Peers - 7799 - Heron Neutron Medical Corp.
Peer Comparison
Compared with companies in Medical Devices listed on TWSE.
- 7799TWSEHeron Neutron Medical Corp.78.80BMarket Cap-36.55%52-week change-151.06P/E (Trailing)‪-250.11%‬Profit Margin
- 1789TWSEScinopharm Taiwan Ltd.14.70BMarket Cap-1.61%52-week change465.00P/E (Trailing)‪1.23%‬Profit Margin
- 4129TWSEUnited Orthopedic Corporation7.93BMarket Cap-41.12%52-week change14.78P/E (Trailing)‪9.09%‬Profit Margin
- 6762TWSEDelta Asia International Corporation5.87BMarket Cap-32.97%52-week change331.25P/E (Trailing)‪2.59%‬Profit Margin
- 1788TWSEHi-Clearance Inc.5.69BMarket Cap-8.20%52-week change14.53P/E (Trailing)‪8.88%‬Profit Margin
- 7820TWSELiying Environmental Protection Technology Co., Ltd.4.07BMarket Cap-81.48%52-week change45.57P/E (Trailing)‪23.43%‬Profit Margin
- 7713TWSEWeLeader Biomedical Co., Ltd.3.35BMarket Cap-0.14%52-week change13.74P/E (Trailing)‪20.61%‬Profit Margin
Profile Summary - 7799 - Heron Neutron Medical Corp.
About
Heron Neutron Medical Corp. is a healthcare technology company specializing in the development, manufacture, and integration of advanced medical equipment, with a primary focus on accelerator-based boron neutron capture therapy (AB-BNCT) systems. These solutions are designed for precise, effective cancer treatment,…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
